novartis ag biotech production facility is slated to open in singapore novartis ag said yesterday it plans to invest about us&# million to build a large scale biotechnology production facility in singapore to support the swiss drug makers biologics portfolio it will be novartiss largest investment in manufacturing capacity to date according to a statement issued to mark the opening of its &# million tablet manufacturing facility in the city state the cell culture production facility will make new products for a variety of medical conditions including rheumatoid arthritis cancer asthma and spinal cord injury novartis said construction will begin next year and is expected to be complete by the facility will employ more than people 
